美好置業(000667.SZ):關聯自然人購買公司開發的商品住宅
格隆匯 4 月 7日丨美好置業(000667.SZ)公佈,公司於2021年4月2日召開第九屆董事會第八次會議,審議通過《關於關聯自然人購買公司開發的商品住宅的議案》:
1、劉南希購買“美好新灘未來新城一期”面積141.70㎡商品住宅一套,交易價格為106.25萬元。
2、馮宗堯購買“美好新灘未來新城一期”面積207.51㎡商品住宅一套,交易價格為181.01萬元。
鑑於以上人員均為公司的關聯自然人,上述交易構成公司的關聯交易。公司獨立董事就上述關聯交易事項進行了事前認可並發表了獨立意見。
上述關聯交易不構成《上市公司重大資產重組管理辦法》規定的重大資產重組,根據《公司章程》和公司《關聯交易管理制度》的相關規定,不需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.